The trials used different designs, timelines, and participants, so TRIUMPH-5 is the study that can settle the direct comparison
Thyroid considerations: Preclinical studies in rodents consistent with findings for other GLP-1 receptor agonists as a class have raised theoretical concerns regarding thyroid C-cell tumours
NICE CG189 recommends a structured approach combining dietary modification, increased physical activity, and behavioural support as first-line treatment
Picking a GLP-1 isnt one-size-fits-all
The Precision Peptide Genetic Test available through PlexusDx may help provide context about an individual's genetic predispositions in peptide metabolism pathwaysincluding GLP1R, GIPR, FTO, and MC4R variantssupporting conversations with providers about whether standard protocols, microdose approaches, or combination compounds align with genetic architecture